Daniel R Chevallard's Net Worth

Daniel R Chevallard's net worth is estimated to be at least $170,143.03 as of 11/22/2024. CoreStreet's estimation of Daniel R Chevallard's net worth is based on their sale of stock and current holding of stock.

Daniel R Chevallard is CFO at Viracta Therapeutics Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,405 units of VIRX stock on 02/27/2024. Their biggest sale was on 11/29/2021 when they sold 4,325 units of Viracta Therapeutics Inc stock for $20,846.50. They typically trade 2 times per year.

Total value of insider buys:
  • $49,999.95
Total value of insider sells:
  • $120,143.08
Most recent insider trade:
  • Feb. 27, 2024

Daniel R Chevallard's Insider Trading History

Viracta Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 27, 2024
CFO3,405$0.73Sell$2,485.65
Nov. 28, 2023
CFO3,720$0.50Sell$1,860.00
Aug. 28, 2023
CFO3,512$1.45Sell$5,092.40
May 25, 2023
CFO3,635$1.42Sell$5,161.70
Feb. 27, 2023
CFO3,599$1.68Sell$6,046.32
Nov. 28, 2022
CFO3,532$2.72Sell$9,607.04
Aug. 26, 2022
CFO3,655$4.02Sell$14,693.10
May 26, 2022
CFO3,596$1.90Sell$6,832.40
Feb. 28, 2022
CFO3,998$2.78Sell$11,114.44
Nov. 29, 2021
CFO4,325$4.82Sell$20,846.50
Nov. 26, 2021
CFO3,254$4.80Sell$15,619.20
Regulus Therapeutics IncTitleAmountPriceTypeTotal Value
July 1, 2019
CFO2,669$1.31Sell$3,496.39
May 15, 2019
CFO10,000$1.41Sell$14,100.00
April 1, 2019
CFO3,253$0.98Sell$3,187.94
July 25, 2017
CFO54,945$0.91Buy$49,999.95